Introduction
A recent study from this laboratory, 1 
using the 2,3-bis[2-m e t h o x y -4 -n i t r o -5 -s u l p h o p h e n y l ] -2H-t e t r a z o l i u m -5 -
carboxanilide inner salt (XTT) tetrazolium salt assay and light microscopy, demonstrated that it is possible to assess the binding of Candida albicans to different surfaces. It was observed that C. albicans binds efficiently to plastic, immobilized bovine serum albumin (BSA) and to the L-configurations of alanine, arginine, leucine, lysine and proline but not to the D-configurations or to any other of the natural amino acids. 1 The pathogenicity of C. albicans appears to be related, in part, to its ability to attach to different types of host surface. The adhesion process is highly dependent upon the nature of the candida cell surface and that of the substratum. [2] [3] [4] There is sparse information concerning the effects of antifungal agents on the ability of C. albicans to bind to different substrates. Some reports have suggested that certain agents, at sub-MIC concentrations, may alter the cell surface hydrophobicity of yeasts, and may also affect the ability of yeasts to bind to different human cell types, and several components of the extracellular matrix (ECM). [5] [6] [7] In this study, the effects of various concentrations of antifungal agent on the ability of yeasts to bind to plastic, immobilized BSA and to immobilized amino acids, was investigated.
Materials and methods

Antifungal agents, chemicals and reagents
Amphotericin B, flucytosine, Type B gelatin from bovine skin, type IV BSA, phenazine methosulphate, XTT tetrazolium salt and dithiothreitol (DTT) were purchased from Sigma Chemical Co. (St Louis, MO, USA). L-Alanine, Larginine, L-leucine, L-lysine and L-proline were purchased from Calbiochem (La Jolla, CA, USA). Fluconazole was obtained from Pfizer (Sandwich, UK) and ketoconazole from Janssen Pharmaceutica (Beerse, Belgium).
Organisms, culture conditions and binding assay C. albicans strains ATCC 10231 and 90028 were obtained from the American Type Culture Collection; CA444, CA74 and CA6406 were kindly provided by Prof. J.-P. Latge (Paris, France), Professor M. Monod (Laussane, Switzerland) and Professor D. Kerridge (Cambridge, UK), respectively. C. albicans strains were grown and prepared for use in binding experiments as described previously. 8 The binding of C. albicans to the different supports was performed as described previously. 1 The effects of pretreatment with antifungal agents or DTT were examined after incubation of yeasts with an antifungal agent at the MIC, or with 10 mM DTT for 4 h at 25°C, with shaking. Free antifungal agent or DTT was then removed by three washes in phosphate buffered saline (PBS). Following washing, 100 L of yeast suspension in PBS (1 10 5 C. albicans cells/mL) was allowed to bind to plastic, immobilized BSA or immobilized amino acids as previously d e s c r i b e d . In concentration-dependent assays, yeasts were pre-incubated in solutions of 0.001-100 mM DTT, 0.001-1.0 mg/L amphotericin B, fluconazole and ketoconazole or 0.01-10 mg/L flucytosine for 4 h at 25°C with shaking. The cells were then washed three times with PBS to remove free antifungal agent or DTT. Following washing, 100 L aliquots of yeasts in PBS (1 10 5 C. albicans cells/mL) were allowed to bind to the various surfaces, and binding was quantified using the XTT tetrazolium assay and routinely confirmed using light microscopy. 1 
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Effects of pre-incubation with DTT or antifungal agents on yeast viability
The effects of pre-incubation of yeasts with different concentrations of DTT or antifungal agent for 4 h were determined. Yeasts were pre-incubated as described above, free DTT or antifungal agent removed by washing three times with PBS, and samples from each pre-incubation or from untreated yeasts were removed and plated on to Sabouraud dextrose agar (Difco). The plates were incubated for 24 h at 25°C and the number of cfu determined. The cfu from pretreatment experiments were expressed as a percentage of the cfu from untreated control cells.
MIC determinations
MIC determinations were performed using a microtitre plate format as described previously 8 . Briefly, wells containing 1. 
Statistical analysis
Data from binding experiments were compared by Student's t-test using the StatWorks program. Significant differences between data were expressed at P 0.01, P 0.05 or P 0.001.
Results
Five different C. albicans strains were used in preliminary studies; these comprised three clinical isolates (CA74, CA444 and CA6406) and ATCC 10231 and ATCC 90028.
As all strains behaved similarly, the ATCC 10231 strain was chosen for all further studies.
MIC determinations and effects of pre-treatment with antifungal agent or DTT on cell viability
The 
Effects of pre-treatment of yeasts with DTT or antifungal agents on binding
Pre-treatment of yeasts with 1 g/L BSA did not affect the ability of yeasts to bind to the non-coated (plastic) surface. However, pre-treatment with either 10 mM DTT or 1 MIC of amphotericin B significantly reduced (P 0.001) the binding by about 85%. By contrast, pre-treatment with the other antifungal agents caused reductions in binding to plastic of only about 40-50% (P 0.01) (Figure 1) .
The effects of pre-treatment of yeasts with BSA, DTT or antifungal agents on the ability of cells to bind to immobilized BSA were also examined. Figure 1 shows that pretreatment of yeasts with 1 g/L BSA significantly (P 0 . 0 0 1 ) reduced the binding of yeasts to immobilized BSA; see also Hawser & Islam 1 Similarly, pre-treatment of yeasts with either 10 mM DTT or 1 MIC amphotericin B also significantly (P 0.001) reduced the binding of yeasts to the immobilized substrate (Figure 1) . Pre-treatment with other antifungal agents at the MIC did not significantly (P 0.1) reduce the ability of yeasts to bind to immobilized BSA. For example, pre-treatment of yeasts with fluconazole, ketoconazole or flucytosine reduced the binding to BSA by 23%, 10% and 6%, respectively.
The effects of various antifungal agents or DTT on the ability of yeasts to bind to immobilized amino acids was examined. In these assays, DTT was shown to reduce the binding of yeasts to all amino acids, even at low concentrations, and complete inhibition of binding was typically observed when yeasts were pre-treated with 1 mM DTT (Figure 2 (Figure 2) . Since flucytosine has a relatively high MIC, the effects of this agent were assessed at concentrations of 0.01-10 mg/L. The inhibition curves for flucytosine suggest that this agent affects the binding of yeasts to immobilized amino acids to a similar degree to that observed for fluconazole and ketoconazole, albeit at higher concentrations (Figure 2) . Surprisingly, pre-treatment with flucytosine at 1 mg/L reduced the binding to L-proline by about 80%, whereas binding to other amino acids was not markedly affected at this concentration (Figure 2 ).
Discussion
Determination of the effects of antifungal or DTT treatments on the ability of yeasts to bind to different substrates showed that at the MIC of amphotericin B, or with 10 mM DTT the binding of yeasts to plastic or to immobilized BSA was drastically reduced. The action of amphotericin B or DTT on binding could be a consequence of either (i) a reduction in cell viability or (ii) direct action on the binding of yeasts to a support. However, no appreciable change in the cfu counts was observed between the pre-treated or untreated cells, except at high concentrations. These agents, therefore, probably act directly on the binding of yeasts to the support. Binding of yeasts to plastic has been suggested to be related to the hydrophobicity of yeast cells 2, 9 whereas binding to BSA is more likely to involve ligand-protein or protein-protein interactions.
By contrast, the azole agents and flucytosine, at the MIC, only partially affected the binding of yeasts to plastic, and minimally affected the binding to immobilized BSA. In terms of the binding of azole-treated yeasts to plastic, the observed reductions in binding are most likely to be due to changes in the cell surface hydrophobicity of yeasts. A recent report suggests that sub-MIC concentrations of fluconazole may increase the hydrophobicity of yeasts, and as a consequence, reduce the binding of yeasts to plastic and to ECM components, including fibronectin and laminin. 9 These agents do not significantly affect the binding of yeasts to BSA. These data would further suggest that binding to BSA requires more specific ligand-protein or proteinprotein interactions.
The yeast cell-amino acid binding interactions are selective and stereospecific. Pre-treatment of yeasts with DTT and amphotericin B attenuated the binding of yeasts to the immobilized amino acids in a dose-dependent manner (IC 50 s of 0.02-0.3 mM for DTT and IC 50 s in the sub-MIC or protein or ligand-protein type interactions as observed with amphotericin B or DTT.
The binding of candida to large proteins, such as BSA and components of the ECM, is likely to involve particular amino acids. Several reports suggest that the binding of yeasts, treated with sub-inhibitory concentrations of antifungal agent, to various cell types can be attenuated. 6, 7, 10 It would have been expected, therefore, that pre-treatment of yeast cells with all antifungal agents would have resulted in attenuation of binding to immobilized amino acids. Only amphotericin B appears to be able to attenuate binding of yeasts when used at sub-MIC concentrations. This finding may be attributed to the mechanism of action of amphotericin B, 11 an agent which rapidly disrupts membrane integrity and is known to cause changes in the mannan content of the cell wall. 12 By contrast, the azoles exert their antifungal action by inhibition of cytochrome P 450 demethylase, 11 and flucytosine by inhibition of RNA and DNA syntheses, 11 and may require much longer pre-treatment periods in order to exert their action. 7 In conclusion, we have shown that marked differences exist in the manner in which C. albicans adheres to different supports. As adherence is a primary step in the pathogenesis of infection, a better understanding of the mechanisms of adherence of C. albicans may prove useful for future antifungal therapy. In this context, studies with amino acids, rather than plastic, mucosal surfaces, cell lines or proteins may offer advantages, and be a better analytical tool for understanding microbial interactions; for example, flucytosine-treated yeasts appeared to bind much less avidly to immobilized proline than to all the other amino acids.
